标准化屋尘螨疫苗特异性免疫治疗常年性变应性鼻炎的疗效观察

详细信息

收稿日期: 2012-02-21

The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis

- Department of Otorhinolaryngology Head and Neck Surgery, Hainan Province People's Hospital, Haikou, 570311

More Information

Received Date: 21 February 2012

摘要: 目的:了解标准化屋尘螨疫苗特异性免疫治疗常年性变应性鼻炎的疗效。方法:对38例变应性鼻炎患者用标准化屋尘螨疫苗特异性免疫治疗3年或3年以上,免疫前后进行症状和体征评分。结果:38例中,显效21例,有效7例,无效10例,总有效率达73.68%。结论:标准化屋尘螨疫苗特异性免疫治疗变应性鼻炎疗效明显。
- 变应原特异性免疫治疗 /
- 标准化屋尘螨疫苗 /
- 鼻炎,变应性,常年性
Abstract: Objective: To study the effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis.Method: Thirty-eight cases of the perennial allergic rhinitis received the subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination for 3 years or more than 3 years. The clinical symptoms and signs were compared before and after treatment.Result: Good result were obtained in 21 of 38 cases, 7 cases effective, and 10 cases ineffective. Total effective rate was 73.68%.Conclusion: The subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination was very effective for the perennial allergen rhinitis.
- subcutaneous allergen immunotherapy /
- Alutard SQ allergy vaccination /
- rhinitis, allergic, perennial

[1]	韩德民. 变应性鼻炎临床诊疗手册[M]. 北京:人民卫生出版社, 2007:11-121.
[2]	BOUSQUET J, LOCKEY R, MALLING H J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper[J]. Allergy Clin Immunol, 1998, 102(4 Pt 1):558-562.
[3]	WANG H, LIN X, HAO C, et al. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients[J]. Allergy, 2006, 61:191-197.
[4]	VALOVIRTA E. Preventive allergy treatment by subcutaneous allergen specific immunotherapy[J]. Allergol Immunol Clin, 2002, 17: 241-244.